Rothschild Australian Bioscience Trust
2
11M
2
- Areas of investment
Summary
The fund was located in Australia. The main office of represented Corporate Investor is situated in the Melbourne.
The usual cause for the fund is to invest in rounds with 5-6 partakers. The meaningful sponsors for the fund in investment in the same round are ONSET Ventures, International Biotechnology Trust, Delphi Ventures. In the next rounds fund is usually obtained by ONSET Ventures, JPMorgan Partners (JPMP), GBS Ventures.
Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight eBioinformatics. Among the most popular fund investment industries, there are Medical, Biotechnology. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The important activity for fund was in 2000. The typical startup value when the investment from Rothschild Australian Bioscience Trust is 5-10 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Investments by industry
- Developer Platform (1)
- Medical (1)
- Health Care (1)
- Information Services (1)
- Biotechnology (1) Show 1 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| NOVASYS MEDICAL | 01 Sep 2001 | Health Care, Medical, Developer Platform | Early Stage Venture | 13M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.